Is National Research Stock a Good Investment?
National Research Investment Advice | NRC |
- Examine National Research's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research National Research's leadership team and their track record. Good management can help National Research navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact National Research's business and its evolving consumer preferences.
- Compare National Research's performance and market position to its competitors. Analyze how National Research is positioned in terms of product offerings, innovation, and market share.
- Check if National Research pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about National Research's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in National Research Corp stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if National Research Corp is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine National Research Stock
Researching National Research's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 37.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 27th of December 2024.
To determine if National Research is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding National Research's research are outlined below:
| National Research generated a negative expected return over the last 90 days | |
| National Research has a frail financial position based on the latest SEC disclosures | |
| About 37.0% of the company outstanding shares are owned by corporate insiders | |
| On 11th of October 2024 National Research paid $ 0.12 per share dividend to its current shareholders | |
| Latest headline from businesswire.com: Signature Healthcare Elevates Patient Experience and Workforce Engagement Through Strategic Partnership With NRC Health |
National Research Quarterly Cash And Short Term Investments |
|
National Research uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in National Research Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to National Research's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact National Research's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises National Research's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2019-08-08 | 2019-06-30 | 0.26 | 0.29 | 0.03 | 11 | ||
2020-02-13 | 2019-12-31 | 0.3 | 0.34 | 0.04 | 13 | ||
2016-02-09 | 2015-12-31 | 0.19 | 0.24 | 0.05 | 26 | ||
2015-11-03 | 2015-09-30 | 0.19 | 0.24 | 0.05 | 26 | ||
2015-02-12 | 2014-12-31 | 0.2 | 0.14 | -0.06 | 30 | ||
2018-02-13 | 2017-12-31 | 0.22 | 0.15 | -0.07 | 31 | ||
2017-08-01 | 2017-06-30 | 0.2 | 0.13 | -0.07 | 35 | ||
2016-11-01 | 2016-09-30 | 0.19 | 0.11 | -0.08 | 42 |
Know National Research's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as National Research is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading National Research Corp backward and forwards among themselves. National Research's institutional investor refers to the entity that pools money to purchase National Research's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Millennium Management Llc | 2024-06-30 | 214.9 K | Wells Fargo & Co | 2024-06-30 | 179.1 K | Hotchkis & Wiley Capital Management Llc | 2024-09-30 | 138.2 K | Northwest & Ethical Investments L.p. | 2024-09-30 | 129.2 K | Eagle Asset Management, Inc. | 2024-06-30 | 124.8 K | Charles Schwab Investment Management Inc | 2024-09-30 | 123.7 K | Bank Of New York Mellon Corp | 2024-06-30 | 123.3 K | Bank Of America Corp | 2024-06-30 | 120.9 K | Comerica Bank | 2024-09-30 | 99.8 K | Kayne Anderson Rudnick Investment Management Llc | 2024-06-30 | 3 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.8 M |
National Research's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 458.72 M.Market Cap |
|
National Research's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.52 | 0.55 | |
| Return On Capital Employed | 0.46 | 0.28 | |
| Return On Assets | 0.25 | 0.20 | |
| Return On Equity | 0.63 | 0.48 |
Determining National Research's profitability involves analyzing its financial statements and using various financial metrics to determine if National Research is a good buy. For example, gross profit margin measures National Research's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of National Research's profitability and make more informed investment decisions.
National Research's Earnings Breakdown by Geography
Please note, the presentation of National Research's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, National Research's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of National Research's management manipulating its earnings.
Evaluate National Research's management efficiency
National Research Corp has Return on Asset of 0.1853 % which means that on every $100 spent on assets, it made $0.1853 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.5856 %, implying that it generated $0.5856 on every 100 dollars invested. National Research's management efficiency ratios could be used to measure how well National Research manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.55, whereas Return On Capital Employed is forecasted to decline to 0.28. At present, National Research's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Return On Tangible Assets is expected to grow to 0.55, whereas Total Assets are forecasted to decline to about 80.7 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.99 | 2.83 | |
| Tangible Book Value Per Share | (0.58) | (0.55) | |
| Enterprise Value Over EBITDA | 21.81 | 36.71 | |
| Price Book Value Ratio | 19.83 | 35.82 | |
| Enterprise Value Multiple | 21.81 | 36.71 | |
| Price Fair Value | 19.83 | 35.82 | |
| Enterprise Value | 834.1 M | 875.8 M |
The strategic initiatives led by National Research's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Dividend Yield 0.0246 | Forward Dividend Yield 0.0246 | Forward Dividend Rate 0.48 | Beta 0.532 |
Basic technical analysis of National Stock
As of the 28th of November, National Research secures the Standard Deviation of 2.57, mean deviation of 1.96, and Risk Adjusted Performance of (0.03). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of National Research Corp, as well as the relationship between them.National Research's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific National Research insiders, such as employees or executives, is commonly permitted as long as it does not rely on National Research's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases National Research insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
National Research's Outstanding Corporate Bonds
National Research issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. National Research Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most National bonds can be classified according to their maturity, which is the date when National Research Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Understand National Research's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing National Research's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 1.96 | |||
| Coefficient Of Variation | (1,847) | |||
| Standard Deviation | 2.57 | |||
| Variance | 6.62 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.55) | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 13.17 | |||
| Value At Risk | (4.72) | |||
| Potential Upside | 3.79 | |||
| Skewness | 0.017 | |||
| Kurtosis | 0.6938 |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.08) | |||
| Mean Deviation | 1.96 | |||
| Coefficient Of Variation | (1,847) | |||
| Standard Deviation | 2.57 | |||
| Variance | 6.62 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.36) | |||
| Total Risk Alpha | (0.55) | |||
| Treynor Ratio | (0.09) | |||
| Maximum Drawdown | 13.17 | |||
| Value At Risk | (4.72) | |||
| Potential Upside | 3.79 | |||
| Skewness | 0.017 | |||
| Kurtosis | 0.6938 |
Consider National Research's intraday indicators
National Research intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of National Research stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 2001.99 | |||
| Daily Balance Of Power | (0.08) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 19.51 | |||
| Day Typical Price | 19.5 | |||
| Price Action Indicator | (0.06) | |||
| Period Momentum Indicator | (0.06) |
National Research Corporate Filings
8K | 14th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 13th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 8th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
F4 | 10th of May 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
National Stock media impact
Far too much social signal, news, headlines, and media speculation about National Research that are available to investors today. That information is available publicly through National media outlets and privately through word of mouth or via National internal channels. However, regardless of the origin, that massive amount of National data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of National Research news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of National Research relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to National Research's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive National Research alpha.
National Research Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards National Research can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
National Research Corporate Management
| CPA CPA | CFO, Fin | Profile | |
| Jennifer Baron | Chief Officer | Profile | |
| Gregory MS | Chief Officer | Profile | |
| Linda Stacy | Principal Officer | Profile | |
| Jona Raasch | Chief Officer | Profile | |
| Jon Boumstein | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Research Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Research. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Research listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.25) | Dividend Share 0.48 | Earnings Share 1.12 | Revenue Per Share 6.013 | Quarterly Revenue Growth (0.06) |
The market value of National Research Corp is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Research's value that differs from its market value or its book value, called intrinsic value, which is National Research's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Research's market value can be influenced by many factors that don't directly affect National Research's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between National Research's value and its price, as these two are different measures arrived at by various means. Investors typically determine if National Research is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Research's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.